skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Indium In 111-DOTA-di-HSG Peptide IMP-288 (Code C82356)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Indium In 111-DOTA-di-HSG Peptide IMP-288

Definition: A radiolabeled divalent histamine-succinyl-glycine (HSG) hapten-peptide linked with the macrocyclic chelator 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) to the radionuclide indium (In) 111. After pretargeting with a bispecific monoclonal antibody (BiMoAB) directed against both a tumor associated antigen (TAA) and the HSG hapten-peptide, the HSG portion of administered indium-In-labeled di-HSG-DOTA peptide IMP-288 binds the anti-HSG portion of the BiMoAB; In-111 radioisotopic activity localized to tumor cells bearing the TAA can then be visualized scintigraphically.

Label: Indium In 111-DOTA-di-HSG Peptide IMP-288

NCI Thesaurus Code: C82356 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL408636  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
In-111-Labeled Di-Histamine-Succinyl-Glycine-DOTA Peptide IMP-288
In-111-Labeled IMP-288
Indium In 111-DOTA-di-HSG Peptide IMP-288

External Source Codes: 
PDQ Closed Trial Search ID 639760
PDQ Open Trial Search ID 639760 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C82356
Legacy_Concept_Name Indium_In-111-DOTA-di-HSG_Peptide_IMP-288
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom